INCY

TYPE Stocks

GROUP Stocks

BASE Incyte Corpo...

SECOND

<% (signals.list.current.rate).substr(0,7) %>

<% (signals.list.current.absolute).substr(0,9) %> (<% signals.list.current.percentage|toFixed:2 %>%)

MARKETS TREND

OPEN

<% (signals.list.current.openrate).substr(0,9) %>

HIGH

<% (signals.list.current.high).substr(0,9) %>

LOW

<% (signals.list.current.low).substr(0,9) %>

START TRADING

Multi Charts

Add to Watchlist

INCY Signals

DON'T WANT TO MISS ANY SIGNAL? GO PREMIUM

ACCESS ALL FX, COMMODITIES & CRYPTO SIGNALS. GO PREMIUM

<% signal.pair %> (<% signal.rate %>) <% signal.action %>

<% signal.status %>

<% signal.analyst %>

Long Term

Entry Price

Stop Loss

Take Profit

<% signal.entryPrice %> N/A

PREMIUM ONLY

<% signal.stopLoss %> N/A

PREMIUM ONLY

<% signal.takeProfit %> N/A

PREMIUM ONLY

<% signal.comment %>

Description

<% signal.description %>

LATEST ANALYSIS

<% item.time_ago %> Ago

<% item.title %>

<% item.deltaTime %>

Full Analysis Feed

Last Updated: Jun 17, 2026 03:16:38 PM (GMT)

INCY: The current market price is 99.7, reflecting a change of -0.1% from the previous price.

Support and Resistance Levels The pivot point is 99.8, with support levels at 99.8, 99.8, and 99.8. Resistance levels are also at 99.8, 99.8, and 99.8.

Indicators RSI is at 7.78, indicating extreme oversold conditions. ATR is at 0.15775, suggesting low volatility. ADX is at 88.87, indicating a strong trend. Parabolic SAR indicates a bearish trend as the price is below its level of 103.9489.

Market Sentiment The market is bearish as the price is below the pivot point of 99.8 and trend indicators suggest continued selling pressure.

INCY Signals & Technical Analysis

Last Updated: <% indicators.interval.updated|date:'MMM d, y h:mm:ss a' %>

Market Trend

Strong Sell

Sell

Neutral

Buy

Strong Buy

Loading Market Trend ...

Market Sentiment

BUY: <% indicators.sentiment.buy.length %> SELL: <% indicators.sentiment.sell.length %> NEUTRAL: <% indicators.sentiment.neutral.length %>

Strong Sell

Sell

Neutral

Buy

Strong Buy

Trend Indicators

NAME

VALUE

ACTION

Bollinger Bands

UPPER: <% indicators.data[indicators.interval.active].bbands.value.upper %>

MIDDLE: <% indicators.data[indicators.interval.active].bbands.value.middle %>

LOWER: <% indicators.data[indicators.interval.active].bbands.value.lower %>

Sell

Buy

Parabolic SAR

<% indicators.data[indicators.interval.active].sar.value %>

Sell

Buy

Standard Deviation

<% indicators.data[indicators.interval.active].stddev.value %>

High Volatility

Low Volatility

Oscillators

NAME

VALUE

ACTION

RSI(14)

<% indicators.data[indicators.interval.active].rsi.value %>

Sell

Buy

MACD(12,26)

<% indicators.data[indicators.interval.active].macd.value %>

Buy

Sell

Neutral

ATR

<% indicators.data[indicators.interval.active].atr.value %>

High Volatility

Low Volatility

STOCH(9,6)

<% indicators.data[indicators.interval.active].stochastics.value %>

Buy

Sell

ADX

<% indicators.data[indicators.interval.active].adx.value %>

High Volatility

Low Volatility

Moving Averages

PERIOD

SIMPLE

EXPONENTIAL

MA5

<% indicators.data[indicators.interval.active].sma5.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema5.value %> Buy Sell

MA10

<% indicators.data[indicators.interval.active].sma10.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema10.value %> Buy Sell

MA20

<% indicators.data[indicators.interval.active].sma20.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema20.value %> Buy Sell

MA50

<% indicators.data[indicators.interval.active].sma50.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema50.value %> Buy Sell

MA100

<% indicators.data[indicators.interval.active].sma100.value %> Buy Sell

<% indicators.data[indicators.interval.active].ema100.value %> Buy Sell

Pivot

PIVOT

CLASSIC

FIBONACCI

CAMARILLA

WOODIE

<% indicators.data[indicators.interval.active].pp.data.result.classic.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s3 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s2 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.s1 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.pp %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r1 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r2 %>

<% indicators.data[indicators.interval.active].pp.data.result.classic.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r3 %>

<% indicators.data[indicators.interval.active].pp.data.result.woodie.r3 %>

About (INCY) Incyte Corporation

Company Background

Incyte Corporation, trading under the symbol INCY on the BMV, is a leading biopharmaceutical company based in the United States that focuses on innovative drug development. Founded in 1991 and headquartered in Wilmington, Delaware, Incyte has built a reputable brand in the life sciences sector, particularly in oncology and hematology. The company is committed to transforming the treatment of cancer by discovering and developing novel medicines that improve patient outcomes. With a robust pipeline of products and a dedication to scientific advancement, Incyte is positioned to make significant contributions to the healthcare landscape.

Market Position

As a prominent player in the biopharmaceutical industry, Incyte has established a strong market position through its focus on targeted therapies and personalized medicine. The company’s flagship product, Jakafi (ruxolitinib), has generated substantial revenue and has set the standard for treatment of certain blood disorders. By leveraging its expertise in molecular biology and clinical research, Incyte continues to expand its portfolio, addressing unmet medical needs and enhancing the quality of life for patients battling complex diseases. Incyte's strategic collaborations and partnerships with other pharmaceutical companies further bolster its market presence and accelerate its research and development initiatives.

Key Financial Highlights

Incyte Corporation has consistently demonstrated solid financial performance, characterized by substantial revenue growth and a focus on reinvesting in research and development. For the fiscal year 2022, the company reported a revenue increase, underlining the strong market demand for its products. Analysts have noted Incyte's potential for future growth, especially as it advances additional therapies through the clinical trial phases. The company maintains a healthy balance sheet with adequate liquidity, allowing for sustained investment in innovation and expansion efforts. Additionally, Incyte's commitment to delivering shareholder value is evident through its strategic initiatives aimed at enhancing operational efficiency and optimizing its pipeline.

Industry Highlights

The biopharmaceutical industry is rapidly evolving, with significant advancements in targeted therapies and immuno-oncology. Incyte is at the forefront of this revolution, capitalizing on the increasing focus on personalized medicine and the demand for more effective treatment options. With its strong pipeline and commitment to scientific excellence, Incyte Corporation is poised to remain a key player in the global biopharmaceutical market.

Check all INCY conversion rates

How to Buy or Trade Incyte Corporation Stock (INCY) with AvaTrade

Trading or investing in Incyte Corporation stock through AvaTrade starts with opening a verified trading account. After registration, complete the KYC verification process by submitting your ID and proof of address, then fund your account using a supported payment method such as bank transfer, debit card, or e-wallet. Once your funds reflect, log into the AvaTrade platform or mobile app and search for the ticker symbol INCY, which represents Incyte Corporation. Before placing a trade, review the live Incyte Corporation share price, market trend, spread, leverage options, and recent market news that could impact the stock price.

The next step is deciding whether you want to buy or sell Incyte Corporation stock. Traders expecting the price to rise typically open a Buy position, while traders expecting weakness in the sector may open a Sell position using CFDs. Enter your preferred trade size, then apply risk management tools such as a stop-loss to limit downside exposure and a take-profit order to secure profits automatically. After confirming the trade, monitor key drivers including Incyte Corporation earnings reports, product or service announcements, business segment performance, revenue growth, and overall stock market sentiment. Many traders also use technical indicators such as moving averages, RSI, and support/resistance levels available on the AvaTrade platform to improve timing and trading decisions.

Related Stocks

BMRN

Biomarin Pharmaceutical Inc.

Industry Biotechnology

Exchange NASDAQ

FRES

Fresh2 Group Limited

Industry Biotechnology

Exchange NASDAQ

UTHR

United Therapeutics Corporation

Industry Biotechnology

Exchange NASDAQ

INCY